TrueLab Biopharmaceutical
PrivateLast Round
VC Round
Jun 22, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TrueLab Biopharmaceutical operates in Healthcare & Life Sciences and is based in Ningbo. Its latest recorded funding round was a VC Round in June 2026.
TrueLab Biopharmaceutical is an immunology-driven biopharmaceutical company that discovers and develops differentiated therapies for immune-mediated inflammatory diseases using its proprietary TrueForge™ AI-powered R&D platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TrueLab Biopharmaceutical Comparables
Compare TrueLab Biopharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Earendil Labs | 82% | |
| Shanghai Novamab Biopharmaceuticals | 81% | |
| Roche Holding | 80% |
For institutional investors. Book with your work email.
TrueLab Biopharmaceutical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
TrueLab Biopharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tencent Exploration | VC Round |
| Loyal Valley Capital | VC Round |
| Legend Capital | VC Round |
| Huagai Capital | VC Round |
| Bayland Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
$53M raised from Loyal Valley Capital and Tencent Exploration.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- licenses_technologyOct 27, 2026
Truelab Bio licenses BYN-002 and BYN-003 to Bionyra, which holds exclusive worldwide rights outside Greater China.
For institutional investors. Book with your work email.
TrueLab Biopharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TrueLab Biopharmaceutical's valuation, stock price, and market status.
Is TrueLab Biopharmaceutical a public or private company?
TrueLab Biopharmaceutical is a private company.
What is the current stock price of TrueLab Biopharmaceutical?
TrueLab Biopharmaceutical is a private company, so its shares have no public market price. Caplight tracks TrueLab Biopharmaceutical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TrueLab Biopharmaceutical worth (valuation)?
Valuation information for TrueLab Biopharmaceutical is not publicly available.
Can I buy TrueLab Biopharmaceutical stock?
TrueLab Biopharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TrueLab Biopharmaceutical's last funding round?
TrueLab Biopharmaceutical's most recent funding round was VC Round on June 22, 2026.
Who are the main investors in TrueLab Biopharmaceutical?
Key investors in TrueLab Biopharmaceutical include Tencent Exploration, Loyal Valley Capital, Legend Capital, Huagai Capital, Bayland Capital.
Will TrueLab Biopharmaceutical IPO soon?
No public IPO plans have been announced for TrueLab Biopharmaceutical.
How can I track TrueLab Biopharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades in TrueLab Biopharmaceutical's shares on secondary markets.